Integrated DNA Technologies acquires Archer™ next generation sequencing research assays to advance actionable scientific discoveries.
NOTE:The same positive and negative controls can be used for both A.s. and L.b. Cas12a (Cpf1) nucleases.
© 2023 Integrated DNA Technologies, Inc.
Trademarks contained herein are the property of Integrated DNA Technologies, Inc. or their respective owners, and may be registered in the USA and/or other jurisdictions. For specific trademark information, see www.idtdna.com/trademarks.